Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Abstract
HepatologyVolume 73, Issue S1 p. 158-191 Review Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference Josep M. Llovet, Corresponding Author Josep M. Llovet josep.llovet@mssm.edu orcid.org/0000-0003-0547-2667 Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS,...
Paper Details
Title
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Published Date
Sep 9, 2020
Journal
Volume
73
Issue
S1
Pages
158 - 191
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History